Clinical Trials Browser

Phase 2/3 × Urethral Neoplasms × Methotrexate × Clear all

NCT00014274 2013-06-12

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

Phase 2/3 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms